Skip to content

Clinical trials

Phase 2 Carcinoma, Intraductal, Noninfiltrating trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Intraductal, Noninfiltrating Phase: Phase 2 Country / region: United States Clear all

59 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20025
20031
20043
20064
20082
20093
20105
20112
20122
20133
20141
20153
20161
20174
20182
20191
20202
20223
20232
20245
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Terminated10
Recruiting9
Active, not recruiting6
Suspended2
Unknown status2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Northwestern University6
National Cancer Institute (NCI)5
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins4
Alliance for Clinical Trials in Oncology3
Dana-Farber Cancer Institute3
M.D. Anderson Cancer Center3
Case Comprehensive Cancer Center2
Rutgers, The State University of New Jersey2
UNC Lineberger Comprehensive Cancer Center2
University of Utah2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Intraductal, Noninfiltrating59
Breast Neoplasms41
Breast Carcinoma In Situ27
Carcinoma, Ductal, Breast5
Carcinoma, Lobular4
Breast Neoplasms, Male2
Hot Flashes2
Dyspareunia1
Fibrocystic Breast Disease1
Lymphedema1

Trials

Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.